Summit Trail Advisors’s Core Scientific CORZ Stock Holding History

Summit Trail Advisors’s Portfolio CORZ Stock Details CORZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$363K	Sell	14,190 -14,931	-51%	-$352K	﹤0.01%	1300
2026 Q1	$436K	Buy	29,121 +2,582	+10%	+$44K	0.01%	1205
2025 Q4	$386K	Sell	26,539 -6,818	-20%	-$119K	0.01%	1152
2025 Q3	$598K	Buy	33,357 +221	+0.7%	+$3.24K	0.01%	1022
2025 Q2	$566K	Sell	33,136 -16,199	-33%	-$162K	0.01%	692
2025 Q1	$357K	Buy	+49,335	New	+$562K	0.01%	292
2024 Q3	–	Sell	-694,079	Closed	-$4.81M	–	724
2024 Q2	$4.81M	Buy	+694,079	New	+$3.55M	0.13%	69

Other funds holding CORZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return

JCAM

Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Summit Trail Advisors's CORZ Position: Q2 2026 in Review

Summit Trail Advisors reduced its Core Scientific (CORZ) stake by 51% in Q2 2026, selling an estimated $352K and leaving 14,190 shares worth $363K. The position accounts for ﹤0.01% of the portfolio, ranked #1300.

Summit Trail Advisors first reported a position in CORZ in Q2 2024 and has held it in 7 quarters since. The position peaked at $4.81M in Q2 2024. 413 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

Summit Trail Advisors held 14,190 shares of Core Scientific worth $363K as of Q2 2026.
Summit Trail Advisors sold 14,931 Core Scientific shares in Q2 2026, an estimated $352K.
Core Scientific made up ﹤0.01% of Summit Trail Advisors's portfolio in Q2 2026, its #1300 holding.
Summit Trail Advisors first reported a position in Core Scientific in Q2 2024 and has held it in 7 quarters since.
Summit Trail Advisors's Core Scientific position peaked at $4.81M in Q2 2024.
413 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Summit Trail Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.